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Abstract
Moderate calorie restriction (CR) (,60% of ad libitum, AL, intake) has been associated with numerous favorable
physiological outcomes in many species, and the insulin/IGF-1 and mTOR signaling pathways have each been proposed as
potential mediators for many of CR’s bioeffects. However, few studies have assessed the widely held idea that CR induces
the down-regulation of the insulin/IGF-1 and/or mTOR pathways in multiple tissues. Accordingly, we analyzed the
phosphorylation status of 11 key signaling proteins from the insulin/IGF-1 (IR
Tyr1162/1163, IGF-1R
Tyr1135/1136, IRS-1
Ser312,
PTEN
Ser380, Akt
Ser473, GSK3a
Ser21, GSK3b
Ser9) and mTOR (TSC2
Ser939, mTOR
Ser2448, P70S6K
Thr412, RPS6
Ser235/236) pathways in 11
diverse tissues [liver, kidney, lung, aorta, two brain regions (cortex and cerebellum), and two slow-twitch and three fast-
twitch skeletal muscles] from 9-month-old male AL and CR Fischer 344 x Brown Norway rats. The rats were studied under
two conditions: with endogenous insulin levels (i.e., AL.CR) and with insulin infused during a hyperinsulinemic-euglycemic
clamp so that plasma insulin concentrations were matched between the two diet groups. The most striking and consistent
effect of CR was greater pAkt in 3 of the 5 skeletal muscles of CR vs. AL rats. There were no significant CR effects on the
mTOR signaling pathway and no evidence that CR caused a general attenuation of mTOR signaling across the tissues
studied. Rather than supporting the premise of a global downregulation of insulin/IGF-1 and/or mTOR signaling in many
tissues, the current results revealed clear tissue-specific CR effects for the insulin signaling pathway without CR effects on
the mTOR signaling pathway.
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Introduction
Calorie restriction (CR) without malnutrition (,60–75% of ad
libitum, AL, intake) has striking biological effects on a wide range
of important outcomes (including improved health, delayed aging
and increased longevity) in many species [1,2,3]. The underlying
mechanisms for these CR-associated benefits remain unclear, but
several lines of evidence have implicated the evolutionarily
conserved insulin/IGF-1 signaling pathway as a potential medi-
ator for significant aspects of the CR phenotype. Interest in the
insulin/IGF-1 signaling pathway is in part attributable to the
recognition that marked reductions in circulating insulin and
moderate decrements in IGF-1 levels are hallmarks of CR [1,4,5].
Furthermore, mutations in insulin/IGF-1 signaling genes of
diverse species (yeast, nematodes, drosophila, mice and rats) have
been reported to be accompanied by many outcomes that are
similar to CR (i.e., delayed aging and increased maximal lifespan)
[1,5,6]. It has been suggested that ‘‘by maintaining plasma insulin
at a markedly low level throughout life, CR is in effect decreasing
insulin signaling’’ [4]. Remarkably, however, the idea that insulin
signaling is reduced by CR in multiple tissues in vivo, an elemental
premise for many of the models of the mechanisms that underlie
CR’s bioeffects, has been the subject of a limited amount of careful
experimentation. The previous studies on CR and the insulin
signaling pathway have rarely included the assessment of more
than one tissue, and the tissue studied has usually been a single
skeletal muscle without regard to muscle fiber type differences.
This narrow perspective does not adequately address the idea that
CR may have significant effects on many tissues.
The target of rapamycin (TOR; mTOR in mammals) pathway
is also an evolutionarily conserved signaling pathway that is both
responsive to nutrient intake implicated as an important modu-
lator of many age-related diseases and maximal lifespan
[7,8,9,10,11,12,13]. Genetic and pharmacologic interventions that
down-regulate the TOR pathway in primitive organisms and
rodents have been reported to result in improved health, delayed
age-related dysfunction and lifespan extension. These outcomes
are reminiscent of the effects of either CR or selected genetic
deficits in the insulin/IGF-1 pathway [8,10]. The TOR pathway
has been described as ‘‘the prime candidate’’ to explain the
benefits of CR on lifespan [8]. Compared to the insulin/IGF-1
pathway, even less is known about the influence of CR on mTOR
signaling in mammalian tissues.
The insulin/IGF-1 and mTOR signaling pathways have each
been widely invoked as likely mediators for many of CR’s
bioeffects [1,4,5,6,8,14,15,16,17,18]. Because there is extensive
cross-talk between the TOR and insulin/IGF-1 pathways
[8,15,19,20], it would be especially valuable to perform simulta-
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tissues. By analyzing the abundance and phosphorylation status of
11 key signaling proteins from the insulin/IGF-1 (IR, IGF-1R,
IRS-1, PTEN, Akt, GSK3a, and GSK3b) and mTOR (TSC2,
mTOR, P70S6K, and RPS6) pathways in 11 diverse tissues [liver,
kidney, lung, aorta, two brain regions (cortex and cerebellum), and
two predominantly slow-twitch and three predominantly fast-
twitch skeletal muscles] from AL and CR rats, we have tested the
widely held idea that CR induces the down-regulation of the
insulin/IGF-1 and/or mTOR pathways. AL and CR rats were
studied under two conditions: with endogenous insulin levels (i.e.,
AL.CR) and with insulin infused during a hyperinsulinemic-
euglycemic clamp so that plasma insulin concentrations were
closely matched between the two diet groups. We hypothesized
that CR would induce tissue-specific effects on selected aspects of
the insulin/IGF-1 and mTOR signaling pathways and that CR’s
effects on both pathways would be modulated by insulin infusion.
Methods
Materials
Reagents and apparatus for SDS-PAGE and immunoblotting
were from Bio-Rad Laboratories (Hercules, CA). MILLIPLEX-
MAP Cell Signaling Buffer and Detection Kit (#48-602), MILLI-
PLEX MAP 11-Plex Akt/mTOR Phosphoprotein Panel (#48-
611; Akt
Ser473, GSK3a
Ser21, GSKb
Ser9, IGF1R
Tyr1135/1136, IR-
Tyr1162/1163, IRS1
Ser312, mTOR
Ser2448, p70 S6 kinase
Thr412,
PTEN
Ser380, RPS6
Ser235/236, and TSC2
Ser939), and total MAP-
mates for Akt (#46-605), GSK3b (#46-689), IGF1R (#46-646),
IR (#46-687), IRS1 (#46-628), mTOR (#46-685), p70 S6 kinase
(#46-630), and PTEN (#46-678) were all purchased from
Millipore (Billerica, MA). Anti-GSK3a (#9338), anti-RPS6
(#2217), anti-TSC2 (3612), and anti-rabbit IgG-horseradish
peroxide conjugate (#7074) were purchased from Cell Signaling
Technology (Danvers, MA). Unless otherwise noted, all other
reagents were purchased from Sigma Chemical (St. Louis, MO) or
Fisher Scientific (Hanover Park, IL).
Animal Treatment
Procedures for animal care were approved by the University of
Michigan Committee on Use and Care of Animals. Male Fischer
344 x Brown Norway, F1 generation rats (FBN) were obtained at 3
months of age from Harlan (Indianapolis, IN). This strain of rats
has previously been demonstrated to respond to CR with
increased lifespan [21]. Rats were housed individually in shoebox
cages and maintained on a 12:12 h light-dark cycle (lights out at
17:00 h). Animals had free access to food chow (Lab Diet; PMI
Nutritional International, Brentwood, MO) and water for a 2 wk
acclimation period. Animals then had free access to food (NIH31
chow, TestDiet, Richmond, IN) and water for another 2 wk
acclimation period. During this time, we measured food
consumption of all rats between 15:30 and 16:30 h every day to
determine baseline food intake (difference between food provided
and food remaining). After the acclimation period, rats were
ranked by weight (lowest to highest) and alternately assigned to the
ad libitum control group (AL) and the calorie restriction treatment
group (CR) so that the initial mean weight and standard error
were similar for both groups. After the 2 wk acclimation, the AL
group received ad libitum access to the NIH31 chow for the
duration of the study. The CR group received NIH31/NIA
fortified chow (TestDiet). The CR group was restricted to 60% of
AL intake gradually over 3 weeks (90%, 75%, 60%). After this
time, the CR group received 60–65% of AL intake daily for
approximately 6 mo (between 182 and 200 days). All CR rats were
fed between 15:30 and 16:30 h each day and food intake of both
groups was measured daily. CR intake was adjusted weekly to 60–
65% of AL intake. All rats were weighed weekly at the same time
of day.
Placement of Catheters
After approximately 6 mo of the feeding protocol, rats from
both diet groups had catheters surgically placed into the jugular
vein and carotid artery to sample blood. All surgical instruments
were initially autoclaved and sterilized using a hot glass bead
sterilizer. Rats were anesthetized with an intraperitoneal injection
of ketamine (50–90 mg?kg
21) and xylazine (5–10 mg?kg
21). The
ventral neck and back of the head was shaved and the skin was
prepared with 3 alternating scrubs of iodine and 70% ethanol.
Under aseptic conditions, a small incision was made superior to
the clavicle, exposing the carotid artery and jugular vein. Both
vessels were catheterized and ligated in place with non-absorbable
suture. Catheters were tunneled subcutaneously using a 16-gauge
needle and exteriorized at the back of the neck via stainless steel
connectors that were coated with medical silicon and fixed
subcutaneously upon the closure of the incision. The catheters
were filled with heparinized saline and tightly plugged with
stainless steel surgical wire. Post-operatively, animals were placed
in an isolator equipped with a heating pad for recovery. Ampicillin
(100 mg?kg
21, intravenously) was given and if needed, buprenor-
phine (0.01–0.5 mg?kg
21, subcutaneously) for pain every 8–12 h.
Warm ringers solution was given to replace lost fluids (1 ml/
100 g?bw
21?h
21 surgery).
Euglycemic-hyperinsulinemic Clamp (clamp) and Saline
Infusion
A week after the catheterization surgery rats underwent the
terminal experiment. At approximately 08:00 on the morning of
clamps and saline infusion experiments, food was removed from
rats (,5 h prior to the start of the clamp and infusion procedures).
The clamp protocol consisted of a 120 min experimental clamp
period (t=0 to 120 min). At t=210 min, a blood sample
(,100 ml) was taken from the arterial catheter for assessment of
basal levels of insulin and glucose. The insulin infusion clamp was
begun at t=0 with a primed-continuous infusion of human insulin
(Novo Nordisk, Princeton, NJ). In addition, saline-infused rats
were used to evaluate insulin signaling and glucose uptake in rats
under basal conditions (without exogenous insulin infusion). Blood
glucose was maintained at ,120 mg?dL
21 during the clamp by
measuring blood glucose with a glucometer (Accu-Check, Roche,
Indianapolis, IN) every 10 min starting at t=0 and infusing 50%
dextrose (Hospira, Lake Forest, IL) at variable rates accordingly.
The glucose infusion rate (GIR) was determined from the average
of the infusion rates over the duration of the clamp protocol.
Plasma insulin concentrations were determined from samples
taken at t=210 and 120 min from the venous catheter using
a commercially available ELISA kit (#EZRNI-13K, Millipore).
Our group has previously demonstrated that CR versus AL rats
have an elevated C-peptide-to-insulin ratio, which is consistent
with a CR-related elevation in insulin clearance [22]. Also
consistent with this interpretation, Feuers and colleagues demon-
strated that CR rats have compared to AL rats injected with
radiolabeled insulin have greater insulin binding in the liver [23].
Accordingly, to achieve the goal of similar plasma values for
insulin in both diet groups, the insulin infusion rate was lower for
AL rats (4.0 mU?kg
21?min
21) compared to CR rats (4.7 to
6.0 mU?kg
21?min
21). At the end of 120 min, the rats were rapidly
anesthetized by injecting pentobarbital into the venous catheter,
and upon loss of pedal reflexes, five skeletal muscles [soleus (SOL),
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adductor longus (ADL)] and six non-skeletal muscle tissues [kidney
(KID), liver (LVR), cerebellum (CBM), brain cortex (CTX), lung
(LNG), and the descending aorta (AOR)] were excised from each
rat.
Tissue Lysate Preparation
Frozen tissues were weighed, and transferred to pre-chilled glass
grinding tubes (Kontes, Vineland, NJ), and homogenized in ice-
cold lysis buffer (1 ml/muscle) using a glass pestle attached to
a motorized homogenizer (Caframo, Wiarton, ON). The lysis
buffer contained T-PER Tissue Protein Extraction Reagent
(#78510, Fisher Scientific), 1 mM EDTA, 1 mM EGTA,
2.5 mM sodium pyrophosphate, 1 mM sodium vanadate, 1 mM
ß-glycerophosphate, 1 mg/ml leupeptin, and 1 mM phenylmethyl-
sulfonyl fluoride. Homogenates were transferred to microfuge
tubes, rotated for 1 h at 4uC, and then centrifuged at 15,000 g for
15 min at 4uC to remove insoluble material. Protein concentration
was measured using the bicinchoninic acid method (#23225,
Fisher Scientific).
Multiplex Analysis
An aliquot of lysate from each tissue was used to determine the
phosphorylation status of 11 proteins in the Akt/mTOR signaling
axis (Akt
Ser473, GSK3a
Ser21, GSKb
Ser9, IGF1R
Tyr1135/1136, IR-
Tyr1162/1163, IRS1
Ser312, mTOR
Ser2448, p70 S6 kinase
Thr412,
PTEN
Ser380, RPS6
Ser235/236, and TSC2
Ser939) using a commercial-
ly available kit (#48-611, Millipore). Another aliquot from each
tissue sample was used in a second multiplex assay to determine
the relative abundance of 8 proteins (Akt, GSK3b, IGF1R, IR,
IRS1, mTOR, p70 S6 kinase, and PTEN). The relative
abundance of the remaining 3 proteins (GSK3a, TSC2, and
RPS6) was determined by immunoblotting as described below
because antibody-bead conjugates for these proteins were not
available for multiplex analysis at the time of the analysis.
Multiplex analysis was performed by the Luminex L200 in-
strument (Luminex, Austin, TX), and data was analyzed by
xPONENT software (Luminex).
Immunoblotting
Equal amounts of protein from each tissue lysate were mixed
with 66 Laemmli buffer, boiled with SDS loading buffer for
5 min, separated by 10% SDS-PAGE, and then transferred to
nitrocellulose. Membranes were rinsed with Tris-buffered saline
plus Tween (TBST; 0.14 M NaCl, 0.02 M Tris base, pH 7.6, and
0.1% Tween), blocked with 5% bovine serum albumin (BSA) in
TBST for 1 h at room temperature and transferred to primary
antibody 1:1000 (either GSK3a, RPS6, or TSC2) in TBST plus
5% BSA overnight at 4uC. Blots were washed 365 min with
TBST and incubated in buffer containing rabbit secondary
antibody (1:20,000 dilution) for 1 h at room temperature.
Membranes were then washed 365 min with TBST and subjected
to enhanced chemiluminescence (#34075, Fisher Scientific) for
visualization of protein bands. Immunoreactive proteins were
quantified by densitometry (AlphaEase FC, Alpha Innotech, San
Leandro, CA).
Statistical Analyses
Data were analyzed using SigmaPlot, version 11.0 (Systat
Software Inc., San Jose, CA). Student’s t-test was used for
comparisons between the two diet groups (AL vs. CR) for body
mass and GIR. Two-way ANOVA was used to determined
significant main effects (diet, CR vs. AL; and infusate, saline vs.
insulin) and interactions for plasma concentrations. Pearson
product moment correlations were used to determine the relation-
ship between signaling proteins. A P value#0.05 was accepted as
statistically significant for these aforementioned comparisons.
Protein phosphorylation data were expressed as a ratio of
phosphorylated to total protein abundance. Two-way ANOVA
was used to determined significant main effects for protein
signaling data. To take into account multiple hypotheses tested
and to reduce the probability of reporting false positives, we used
a Bonferroni correction, whereby the generally accepted level of
significance (i.e. P value#0.05) was divided by 363 (11
analytes611 tissues63 comparisons, i.e., 2 main effects and 1
interaction). With this correction implemented, a P val-
ue#0.000138 was accepted as statistically significant for the
protein signaling data. All data are presented as mean 6 SEM.
Results
Body Mass
As expected, AL vs. CR rats had a significantly (P#0.05) larger
body mass (saline-infused: 430.4615.3 g vs. 261.064.7 g; and
clamped: 420.8610.5 g vs. 272.769.7 g).
Blood Glucose, GIR, and Plasma Insulin Levels
Prior to the clamp, there was a main effect of diet (P#0.05) for
plasma glucose levels (CR,AL) as there was a 10% decrease in the
CR-INS group compared to the AL-INS group, and a 6%
decrease in the CR-SLN group compared to the AL-SLN group
(Table 1). During the infusion period, blood glucose was
significantly greater (P#0.05) for insulin infused vs. saline infused
rats. As planned, blood glucose was successfully maintained at
similar levels between the AL-INS and CR-INS group
(119.6 mg?dL
21 vs. 121.5 mg?dL
21, respectively; Table 1). The
GIR was 109% greater (P#0.05) in the CR-INS group
(34.362.2 mg?kg
21?min
21) compared to the AL-INS group
(16.460.7 mg?kg
21?min
21).
Prior to the infusion period, there was a main effect of diet
(P#0.05) for plasma insulin levels (CR,AL) as the CR-SLN group
had 46% lower plasma insulin levels compared to the AL-SLN
group and the CR-INS group had 49% lower plasma insulin
compared to the AL-INS group (Table 1). At the end of the clamp
protocol, there was a main effect of insulin (P#0.05) for plasma
insulin levels (INS.SLN). As intended, the CR-INS
(159.9 mU?mL
21) and AL-INS (164.6 mU?mL
21) groups were
successfully elevated to very similar values (Table 1).
Protein Phosphorylation
To eliminate false positives due to multiple comparisons in the
protein phosphorylation data, we used a high stringency statistical
threshold (P#0.000138). The most consistent effects were found
for insulin signaling in skeletal muscle. For pAkt
Ser473, there was
a significant (P#0.000138) main effect of diet (CR.AL) in the
EPI, TA, and PLN, and a significant (P#0.000138) main effect of
insulin infusion (INS.SLN) in the SOL, TA, and PLN (Figs. 1 &
2). There was also a significant (P#0.000138) main effect of insulin
infusion (INS.SLN) in the SOL for pIR
Tyr1135/1136 (Fig. 1). There
were no significant effects of diet or insulin infusion in any of the
other tissues (Figs. 3, 4, 5).
Correlations
We calculated correlations between the phosphorylation of Akt
and p70S6K and the phosphorylation of the respective substrates
of these two kinases (Table 2). There was a significant (P#0.05)
positive correlation between pAkt
Ser473 and pGSK3a
Ser21 in the
Calorie Restriction and Tissue-Specific Signaling
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(P#0.05) positive correlation between pAkt
Ser473 and pGSK3a-
Ser21 in the LVR, AOR, and KID. In 4 of the 5 muscles studied
there was a significant (P#0.05) positive correlation between
pAkt
Ser473 and pGSK3b
Ser9). In all 6 of the non-skeletal muscles
tissues, there was significant (P#0.05) relationship between
pAkt
Ser473 and pGSK3b
Ser9. There was a significant (P#0.05)
positive correlation between pAkt
Ser473 and pTSC
Ser939 in both of
the predominantly slow-twitch muscles (SOL and ADL), but not in
any of the predominantly fast-twitch muscles (EPI, TA and PLN).
In the non-skeletal muscles tissues, there was significant (P#0.05)
positive correlation between pAkt
Ser473 and pTSC2
Ser939 in the
CTX, KID, and LNG. There was a significant (P#0.05) positive
correlation between pP70S6K
Thr412 and pRPS6
Ser235/236 in 4 of
the 5 muscles. In the non-skeletal muscle tissues, there was
a significant (P#0.05) positive correlation between pP70S6K
Thr412
and pRPS6
Ser235/236 in the CTX and KID.
Protein Abundance
There were no significant effects of diet or insulin infusion on
protein abundance in the 11 tissues studied (Figures S1, S2, S3, S4,
S5).
Discussion
Calorie restriction (CR) has been demonstrated to extend
normal lifespan and improve health in many species. There is
a great deal of speculation that many of the beneficial effects of CR
are attained, at least in part, by suppression of the insulin/IGF-1
and/or TOR signaling pathways. Remarkably, only a few studies
have assessed the frequent assertion that CR causes attenuated
activation of these pathways. Accordingly, we performed the
current study as the initial step in probing the effects of CR and
insulin on insulin/IGF-1 and mTOR signaling of multiple tissues
in vivo. We determined protein phosphorylation of several key
signaling proteins comparing AL and CR rats in two different
conditions: 1) endogenous insulin levels (,2-fold greater insulin for
AL vs. CR), and 2) with insulin elevated to a similar level in both
diet groups. Consistent with our hypothesis, we found that CR
induced tissue-specific effects on certain aspects of the insulin/
IGF-1 signaling pathway. Furthermore, the results do not support
the notion that CR leads to a general reduction of insulin
signaling. Rather, we observed an increase in pAkt in several
skeletal muscles for CR compared to AL rats, and no evidence for
a uniform change in insulin signaling of the other tissues of CR
rats. Additionally there were no CR-related effects on the mTOR
pathway proteins, and this pathway was also not consistently
attenuated by CR in any of the tissues studied.
It is useful to interpret the current results for the insulin
signaling pathway in skeletal muscle that were sampled after in
vivo insulin infusion together with the results from a series of our
previous experiments investigating the effects of CR on insulin
signaling of isolated skeletal muscles [24,25,26,27,28,29,30,31].
The most consistent finding from the earlier studies with isolated
muscles is that CR, compared to AL-fed rodents, are characterized
by a robust increase in insulin-stimulated Akt phosphorylation
[24,26,27]. In a recent study from our group [24], male 9-mo old
FBN rats underwent the identical feeding protocol as the rats used
in current study, had EPI (predominantly fast-twitch) and SOL
(predominantly slow-twitch) muscles excised and analyzed for the
effects of CR and insulin on signaling ex vivo. There was no
significant difference in insulin receptor tyrosine phosphorylation
(pIR) between AL and CR muscles (EPI or SOL) that were
incubated either in the absence of insulin or with a physiologic
insulin dose (200 mU?ml
21; similar to the resulting insulin
concentration of the insulin-infused rats in the current study).
There was also no difference between CR vs. AL rats for pAkt in
either EPI or SOL muscles incubated without insulin. However,
with a physiologic (200 mU/ml) insulin dose, pAkt was signifi-
cantly greater in CR vs. AL rats in both muscles. The CR-related
differences found in isolated muscles are not attributable to the
direct influence of systemic factors (e.g., CR-related differences in
blood flow, hormone concentrations, etc.). Therefore, in skeletal
muscles from AL compared to CR rats studied at an equal
physiologic insulin concentration ex vivo, activation of key aspects
of the insulin signaling pathway are either similar or greater for
CR to AL rats.
The current data extend these earlier studies for CR effects on
insulin signaling in the EPI and SOL by assessing the SOL and
EPI along with 3 other skeletal muscles (including the pre-
dominantly slow-twitch ADL and predominantly fast-twitch TA
and PLN) under in vivo conditions. There was a significant Diet-
induced effect on pAkt (CR.AL) in 3 of the 5 skeletal muscles that
were studied (EPI, TA and PLN) with no evidence for a CR-
associated decrement in pAkt in the other muscles studied (SOL
and ADL). In none of the muscles was the greater pAkt
attributable to greater pIR in CR vs. AL rats. The ,2-fold
greater GIR during the clamp for CR vs. AL rats with plasma
insulin levels of ,160 mU/ml insulin for both groups in the
current study was very similar to the ,2-fold greater GIR for CR
(70% of AL intake for 4 years) vs. AL cynomologus monkeys
undergoing a clamp with plasma insulin levels of ,250 mU/ml in
both diet groups [32]. Insulin-stimulated pAkt in the vastus
lateralis was also greater for CR vs. AL monkeys. However, in
contrast to the current results, pIR values were greater in the
vastus lateralis of CR vs. AL monkeys. Previous research has also
compared insulin signaling in hindlimb skeletal muscle from AL
and CR mice after a large bolus of insulin (10 IU/kg) was injected
into their portal vein [33,34]. Consistent with results for either rats
or monkeys, the pAkt from insulin-stimulated muscle was greater
Table 1. Blood glucose and plasma insulin concentrations.
AL-SLN CR-SLN AL-INS CR-INS ANOVA
Blood Glucose Pre-Infusion (mg?dL
21) 112.362.0 10662.3 112.762.5 101.564.0 *Diet
Blood Glucose Avg. during Infusion (mg?dL
21) 106.062.3 98.463.1 119.663.1 121.564.7 *Insulin
Plasma Insulin Pre-Infusion (mU?mL
21) 55.764.0 30.065.0 61.765.0 31.263.8 *Diet
Plasma Insulin Post Infusion (mU?mL
21) 43.966.7 25.263.5 164.6611.1 159.969.8 *Insulin
Values are means 6 SEM. n=6 rats per treatment group.
*P#0.05, Main Effect of Diet or Insulin Infusion.
doi:10.1371/journal.pone.0038835.t001
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in these mice. Differences among studies for CR effects on pIR
may be related to differences between species and/or differences in
the insulin-stimulation protocols (e.g., insulin dose, duration of
exposure, etc.). We previously found significantly greater pIR for
CR vs. AL rats in SOL and EPI muscles studied ex vivo with
a supraphysiologic insulin dose (5000 mU/ml), but not with
a physiologic insulin dose (200 mU/ml) [24]. Regardless, there
was no evidence from any of these species that CR results in
attenuated insulin signaling in skeletal muscle. Importantly, in the
Figure 1. Insulin/IGF-1 and mTOR signaling in predominantly slow-twitch muscles. Open bars are the AL-SLN group, gray bars are the CR-
SLN group, hatched bars are the AL-INS group, and black bars are the CR-INS group. Values are expressed as phosphorylated-to-total protein ratio.
Main effects of Diet, Insulin Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from 2-way ANOVA are shown in each panel. *P#0.000138.
Data are means 6 SEM. n=6 rats per diet group and treatment.
doi:10.1371/journal.pone.0038835.g001
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38835Figure 2. Insulin/IGF-1 and mTOR signaling in predominantly fast-twitch muscles. Open bars are the AL-SLN group, gray bars are the CR-
SLN group, hatched bars are the AL-INS group, and black bars are the CR-INS group. Values are expressed as phosphorylated-to-total protein ratio.
Main effects of Diet, Insulin Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from 2-way ANOVA are shown in each panel. *P#0.000138.
Data are means 6 SEM. n=6 rats per diet group and treatment.
doi:10.1371/journal.pone.0038835.g002
Figure 3. Insulin/IGF-1 and mTOR signaling in the brain. Open bars are the AL-SLN group, gray bars are the CR-SLN group, hatched bars are
the AL-INS group, and black bars are the CR-INS group. Values are expressed as phosphorylated-to-total protein ratio. Main effects of Diet, Insulin
Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from 2-way ANOVA are shown in each panel. Data are means 6 SEM. n=6 rats per diet
group and treatment.
doi:10.1371/journal.pone.0038835.g003
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,50% lower than AL values, phosphorylation of IR and Akt was
similar or greater for saline-infused CR rats in all 5 muscles.
A very limited number of previous studies have addressed the
effects of CR on the insulin signaling pathway in non-skeletal
muscle tissues. In the current study, the skeletal muscles were
relatively consistent with regard to greater pAkt in response to
insulin infusion and diet (CR.AL), but these changes in pAkt
were absent for all other tissues that were studied. It is also notable
that pAkt did not correlate with both of the two isoforms of
Figure 4. Insulin/IGF-1 and mTOR signaling in the liver and aorta. Open bars are the AL-SLN group, gray bars are the CR-SLN group, hatched
bars are the AL-INS group, and black bars are the CR-INS group. Values are expressed as phosphorylated-to-total protein ratio. Main effects of Diet,
Insulin Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from 2-way ANOVA are shown in each panel. Data are means 6 SEM. n=6 rats per
diet group and treatment.
doi:10.1371/journal.pone.0038835.g004
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pAkt and pGSK3b was consistently found in the 11 tissues
(observed in 4 of 5 muscles with a trend in the PLN, and significant
in all 6 non-muscle tissues), but significant correlations between
pAkt and pGSK3a were only found in the TA, LVR, AOR, and
KID. The differential responses of pGSK isoforms to Diet and
Insulin infusion are not unexpected, as differences between the
a and b isoforms have often been previously noted in other models
Figure 5. Insulin/IGF-1 and mTOR signaling in the kidney and lung. Open bars are the AL-SLN group, gray bars are the CR-SLN group,
hatched bars are the AL-INS group, and black bars are the CR-INS group. Values are expressed as phosphorylated-to-total protein ratio. Main effects of
Diet, Insulin Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from 2-way ANOVA are shown in each panel. Data are means 6 SEM. n=6 rats
per diet group and treatment.
doi:10.1371/journal.pone.0038835.g005
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[35,36,37,38,39,40]. Taken together, the results of the current
study demonstrate that the effects of CR on the insulin signaling
pathway, and specifically on pAkt, are not uniform, but are highly
tissue-specific.
In recent years there has been a great deal of interest in the
mTOR pathway as a potential target for regulating health and
lifespan. Downregulation of the mTOR pathway through genetic
or pharmacological manipulation has been reported to be
beneficial for health and longevity in rodents [1,9,19]. Very few
previous studies have investigated the effects of CR on mTOR
signaling in rodents. Bonkowski et al. observed a decrease in
pmTOR in mouse hindlimb muscle that was studied with
endogenous insulin that was ,40% lower for CR vs. AL mice
[33]. Zheng et al. reported no CR-induced effect on pP70S6K
values in the liver of rats with endogenous insulin values that were
not reported [41]. In the current study, there was a significant
correlation between pP70S6K and pRPS6 in 4 of the 5 muscles as
well as the CTX and KID, but the data do not support the idea
that marked attenuated mTOR signaling is a universal character-
istic of CR. It is notable that the lack of CR-related attenuation of
mTOR signaling was found using either a high stringency
threshold for statistical significance with the Bonferroni correction
or with a low stringency threshold in the absence of this
adjustment.
In conclusion, CR has diverse, tissue-specific effects on the
phosphorylation of key proteins in the insulin/IGF-1 signaling
pathway. CR did not induce a uniform attenuation of insulin/
IGF-1 signaling, rather the most striking and consistent effect of
CR was elevated pAkt in skeletal muscle. There were no
significant effects of CR on the phosphorylation of mTOR
signaling pathway proteins, and there was no evidence for
a general attenuation of the mTOR pathway. The current results
provide the most comprehensive data set currently available for
CR effects on the insulin/IGF1 and mTOR pathways in multiple
tissues, and they do not provide evidence supporting the notion
that the beneficial effects of CR may be largely attributable to
a general downregulation of insulin/IGF-1 and/or mTOR
signaling in many or most tissues. However, it is important to
recognize that these results do not eliminate the possible roles of
these pathways for specific effects of CR. For example, the
enhanced pAkt in skeletal muscles is likely important for improved
insulin-mediated glucose disposal with CR [24,27]. Furthermore,
CR effects on specific cell types may be obscured in whole tissue
analyses. There may also be CR effects on both pathways that will
be revealed by evaluating diurnal fluctuations in signaling events.
Although the current results refute the idea that CR induces
a uniform attenuation of insulin/IGF-1 and/or mTOR signaling
in most tissues of 9 month-old rats, it will be important for future
research to elucidate possible CR effects in older animals and in
different species, as well as the more complex and nuanced
influence of CR on these pathways in multiple tissues and cell
types.
Supporting Information
Figure S1 Total protein abundance in predominantly
slow-twitch muscles. Open bars are the AL-SLN group, gray
bars are the CR-SLN group, hatched bars are the AL-INS group,
and black bars are the CR-INS group. Main effects of Diet, Insulin
Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from
2-way ANOVA are shown in each panel. Data are means 6 SEM.
n=6 rats per diet group and treatment.
(TIF)
Figure S2 Total protein abundance in predominantly
fast-twitch muscles. Open bars are the AL-SLN group, gray
bars are the CR-SLN group, hatched bars are the AL-INS group,
and black bars are the CR-INS group. Main effects of Diet, Insulin
Infusion (Ins), and Diet6Insulin Infusion Interactions (D6I) from
2-way ANOVA are shown in each panel. Data are means 6 SEM.
n=6 rats per diet group and treatment.
(TIF)
Figure S3 Total protein abundance in the brain. Open
bars are the AL-SLN group, gray bars are the CR-SLN group,
hatched bars are the AL-INS group, and black bars are the CR-
INS group. Main effects of Diet, Insulin Infusion (Ins), and
Diet6Insulin Infusion Interactions (D6I) from 2-way ANOVA are
shown in each panel. Data are means 6 SEM. n=6 rats per diet
group and treatment.
(TIF)
Figure S4 Total protein abundance in the liver and
aorta. Open bars are the AL-SLN group, gray bars are the CR-
Table 2. Correlations.
pAkt
Ser473 vs. pGSK3a
Ser21 pAkt
Ser473 vs. pGSK3b
Ser9 pAkt
Ser473 vs. pTSC2
Ser939 pP70S6K
Thr412 vs. pRPS6
S235/S236
R Value R Value R Value R Value
SOL 0.043 0.564* 0.463* 0.57*
ADL 0.420 0.487* 0.691* 0.690*
EPI 0.386 0.625* 20.248 0.108
TA 0.502* 0.690* 0.293 0.482*
PLN 0.114 0.350 0.107 0.531*
CTX 0.003 0.779* 0.753* 0.597*
CBM 0.336 0.545* 20.037 0.146
LVR 0.681* 0.923* 20.357 20.094
AOR 0.796* 0.889* 0.138 20.115
KID 0.479* 0.887* 0.747* 0.463*
LNG 0.210 0.405* 0.604* 0.093
*P#0.05.
doi:10.1371/journal.pone.0038835.t002
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are the CR-INS group. Main effects of Diet, Insulin Infusion (Ins),
and Diet6Insulin Infusion Interactions (D6I) from 2-way
ANOVA are shown in each panel. Data are means 6 SEM.
n=6 rats per diet group and treatment.
(TIF)
Figure S5 Total protein abundance in the kidney and
lung. Open bars are the AL-SLN group, gray bars are the CR-
SLN group, hatched bars are the AL-INS group, and black bars
are the CR-INS group. Main effects of Diet, Insulin Infusion (Ins),
and Diet6Insulin Infusion Interactions (D6I) from 2-way
ANOVA are shown in each panel. Data are means 6 SEM.
n=6 rats per diet group and treatment.
(TIF)
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